On January 20, 2026, Genezen, a top gene therapy Contract Development and Manufacturing Organization (CDMO) based in Lexington, Massachusetts, and Atsena Therapeutics, a clinical-stage gene therapy company from Durham, North Carolina, announced a collaboration. Atsena Therapeutics aims to harness the transformative potential of genetic treatments. The partnership allows Genezen to provide its expertise in gene therapy manufacturing to support Atsena Therapeutics. This collaboration signifies a significant step forward in advancing gene therapy research and development efforts.
